Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Analysis of clinical and imaging predictors of response to corticosteroid therapy in inflammatory dacryoadenitis.

Orbit (Amsterdam, Netherlands)·2026
Same author

Ocular thelaziasis mimicking an eyelid tumor: <i>Pseudotumoral eyelid thelaziasis</i>.

Orbit (Amsterdam, Netherlands)·2026
Same author

Surgical Management of Essential Blepharospasm: Long-Term Results After Orbicularis Myectomy.

Ophthalmic plastic and reconstructive surgery·2026
Same author

French recommendations for the use of imaging in giant cell arteritis.

Joint bone spine·2026
Same author

Omics in hereditary optic neuropathies: A systematic review of clinical studies with an integrated point of view.

Survey of ophthalmology·2026
Same author

Cross-species transcriptomics identify mineralocorticoid receptor pathway overactivation as a central driver of ocular rosacea.

Nature communications·2026

Related Experiment Video

Updated: Jun 18, 2026

Optical Coherence Tomography: Imaging Mouse Retinal Ganglion Cells In Vivo
08:17

Optical Coherence Tomography: Imaging Mouse Retinal Ganglion Cells In Vivo

Published on: September 22, 2017

Dysthyroid optic neuropathy: atypical initial presentation and persistent visual loss.

Aurore Mensah1, Catherine Vignal-Clermont, Chadi Mehanna

  • 1Oculoplastics and Neuro-Ophthalmology department of Rothschild Eye Foundation of Paris, France. retinaa@gmail.com

Orbit (Amsterdam, Netherlands)
|November 26, 2009
PubMed
Summary

Identifying risk factors for Dysthyroid Optic Neuropathy (DON) is crucial. Inferior altitudinal visual field defects and lack of response to steroids indicate poor visual recovery in DON patients.

More Related Videos

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

Related Experiment Videos

Last Updated: Jun 18, 2026

Optical Coherence Tomography: Imaging Mouse Retinal Ganglion Cells In Vivo
08:17

Optical Coherence Tomography: Imaging Mouse Retinal Ganglion Cells In Vivo

Published on: September 22, 2017

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

Area of Science:

  • Ophthalmology
  • Endocrinology
  • Neuroscience

Background:

  • Dysthyroid Optic Neuropathy (DON) is a serious complication of Graves' orbitopathy.
  • It can lead to irreversible vision loss if not managed promptly.

Purpose of the Study:

  • To identify risk factors associated with poor visual recovery in patients with DON.
  • To analyze prognostic factors for visual outcomes in DON despite intensive treatment.

Main Methods:

  • Retrospective analysis of 29 consecutive patients with DON between 1997 and 2007.
  • Review of demographic, clinical, and visual function data at multiple time points.
  • Statistical analysis to determine significant prognostic factors for visual recovery.

Main Results:

  • DON developed in 56 eyes of 29 patients.
  • 16 eyes (28%) showed no vision improvement despite treatment.
  • Inferior altitudinal visual field defects (p=0.0004) and lack of response to IV steroids (p=0.011) were linked to poor recovery.

Conclusions:

  • DON prognosis varies significantly.
  • Non-inflammatory, possibly vascular, factors may contribute to atypical DON cases.
  • Early recognition and prompt surgical intervention may improve outcomes for specific DON patients.